Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults

Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults

The emergence of Omicron variants coincided with declining vaccine-induced protection against SARS-CoV-2. Two bivalent mRNA vaccines, mRNA-1273.222 (Moderna) and BNT162b2 Bivalent (Pfizer-BioNTech), were developed to provide greater protection against the predominate circulating variants by includin...

Full description

Bibliographic Details
Main Authors: Hagit Kopel, Van Hung Nguyen, Catherine Boileau, Alina Bogdanov, Isabelle Winer, Thierry Ducruet, Ni Zeng, Mac Bonafede, Daina B. Esposito, David Martin, Andrew Rosen, Nicolas Van de Velde, Sten H. Vermund, Stefan Gravenstein, James A. Mansi
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Vaccines
Subjects:
mRNA-1273.222
BNT162b2 Bivalent vaccine
bivalent vaccine
COVID-19 vaccine
hospitalization
symptomatic disease
Online Access:https://www.mdpi.com/2076-393X/11/11/1711

Internet

https://www.mdpi.com/2076-393X/11/11/1711

Similar Items